Bedinvetmab (Librela) side effects in dogs

19,619 reports sent to the FDA between 2023 and 2026 involve Bedinvetmab in dogs. The most reported problems were loss of appetite, lethargy, vomiting. 62% were marked serious, and where it was recorded, signs eased after stopping the medicine in 29% of cases.

19,619Reports
62%Marked serious
43%Only medicine involved
12%Recovered
20%Died or euthanised
SponsoredWorried about your pet? Ask a veterinarian online, 24/7

About this medicine

Bedinvetmab reduces osteoarthritis pain in dogs (monthly injection).

Products with this ingredient include Librela. The FDA hides brand names in its public data, so these reports cover every product with the same active ingredients.

Most reported side effects

2,441 12%
2,264 12%
2,204 11%
1,800 9.2%
1,710 8.7%
1,579 8.0%
1,332 6.8%

Share = percentage of this medicine's reports that mention the problem. One report can list several problems.

Reports that it didn't work

Some reports are about the medicine not working (for example a dog still getting fleas or heartworm), not about a side effect.

Didn't prevent heartworm
15 0.1%
Didn't stop worms
10 0.1%
Didn't stop fleas
7 0.0%
Didn't stop ticks
4 0.0%

How soon problems started

Same day
3,925 23%
1–2 days
2,563 15%
3–7 days
2,113 12%
1–4 weeks
3,916 23%
Over a month
4,867 28%

Time from the first dose to the first sign, where both dates were reported (17,384 reports).

How the animals did

Recovered
2,296 12%
Recovered with lasting effects
36 0.2%
Still unwell when reported
10,600 54%
Died
1,351 6.9%
Euthanised
2,514 13%
Not known
2,822 14%

Breeds named most often

Popular breeds appear more often because there are more of them.

Other monoclonal antibody injections for dogs